title: InforMatrix nucleoside/nucleotide reverse transcriptase inhibitor 'backbones'.
abstract: InforMatrix is an interactive decision matrix technique. This paper describes the use of InforMatrix to determine an order of merit within the various nucleoside and nucleotide reverse transcriptase inhibitors. In the order of merit, six criteria (effectiveness, safety, tolerance, convenience, usability and costs) are weighted against each other. Data necessary for this weighting process are derived from literature as well as personal practical experience. This article gives an overview of the most relevant information from clinical trials, cohort studies and databases concerning backbones consisting of two nucleoside/nucleotide reverse transcriptase inhibitors in the treatment of HIV infections, as well as a description of the interactive decision matrix technique. By using this interactive matrix technique, a rational consideration of the treatment options for backbones consisting of two nucleoside/nucleotide reverse transcriptase inhibitors becomes possible.
authors.affiliation: University Hospital Maastricht, Maastricht, The Netherlands.
authors.forename: Gerrit
authors.initials: G
authors.lastname: Schreij
authors.forename: Robert
authors.initials: R
authors.lastname: Janknegt
mesh_terms: D000740:Anemia / Q000139:chemically induced; D002986:Clinical Trials as Topic / Q000379:methods; D003661:Decision Support Techniques; D006801:Humans; D008962:Models, Theoretical; D009705:Nucleosides / Q000009:adverse effects / Q000627:therapeutic use*; D009711:Nucleotides / Q000009:adverse effects / Q000627:therapeutic use*; D010195:Pancreatitis / Q000139:chemically induced; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D009705:Nucleosides; D009711:Nucleotides; D018894:Reverse Transcriptase Inhibitors